IONQ 1-day forecast by Grok 4.5

Grok 4.5's 1-day forecast for IONQ, made 2026-10-20: expected range $29.80 to $33.20 at 42% confidence. Settled at $32.31: direction called incorrectly, score 30.3.

AssetIONQ
ModelGrok 4.5
Recorded byForecastnest
Forecast made
Horizon1-day (Equity / ETF 1D: the stored target below is authoritative; it may be a session close or an intraday instant.)
Window closes
Price when asked$31.61
Price the model reported$31.55
Expected range$29.80 to $33.20
Confidence42%
Prompt styleNo data
StatusSettled
Actual close$32.31
Traded range in the window$31.18 to $32.41
ResultDirection called incorrectly
Score30.3 of 100

The model's reasoning

(1) What you found, and where: Live quotes from Yahoo Finance, StockAnalysis, Motley Fool and MarketWatch around midday EDT on 2026-10-20 show IONQ trading near $31.50-$31.65 (open ~$30.28, day range $30.19-$32.17, prior close $30.78). Volume partial-session ~11M shares. Sources: https://finance.yahoo.com/quote/IONQ, https://stockanalysis.com/stocks/ionq, https://www.fool.com/quote/nyse/ionq. NYSE regular session, USD, share volume.

(2) The current market regime as you read it: High-beta quantum name in corrective downtrend after dilution. Recent sessions show large swings on elevated volume following the $2B equity offering. Price sits well below 20-day highs amid profit-taking and share-count expansion; short-term bounce from prior-day lows is underway but lacks conviction against the broader multi-week decline.

(3) Price range justification, with the levels and volatility you are using: Anchored to ~$31.55 quote. Daily ATR recently 2-4 points given swings such as Oct 15 high-low $4.33. Range $29.80-$33.20 allows for continuation of the morning recovery or retest of the Oct 19 low near $30.29 / Oct 15 low $30.03, consistent with recent realized volatility and average volume ~25M.

(4) Scheduled or likely catalysts inside the window: No major scheduled catalysts inside the 24-hour window ending 2026-10-21 16:52 UTC. Recent verified events (Oct 14 $2B equity offering priced at premium to prior close, Elisity all-stock acquisition announcement Oct 12, DARPA QBI Stage C up to $300M Oct 7, Cambridge Quantum Innovation Centre Oct 15) are already priced; next earnings estimated Nov 4. These are fundamental (balance-sheet strength, tech validation) but diluted sentiment near-term.

(5) The strongest counter-argument, and what would invalidate your call: Strongest counter is the intraday rebound from the prior close and technical demos/DARPA progress supporting longer-term narrative; a sustained move above the Oct 15 high $34.36 on rising volume would invalidate the neutral/mild-down bias by signaling dilution digestion. Conversely, a close back below $30.00 would confirm continuation of the post-offering decline.

(6) Why your confidence is the number it is: 42% reflects live quote access and clear recent OHLCV but high intrinsic volatility of the name, unfinished session at window start, and absence of fresh catalysts inside the short horizon; direction is near-noise.

Daily OHLCV (last five completed sessions, oldest to newest; NYSE, split-adjusted USD, share volume; sources Yahoo Finance / StockAnalysis / MarketWatch): 2026-10-13 O 35.82 H 35.99 L 34.48 C 34.73 V 23468100; 2026-10-14 O 33.15 H 33.39 L 31.05 C 31.42 V 41353700; 2026-10-15 O 30.55 H 34.36 L 30.03 C 34.35 V 48163300; 2026-10-16 O 33.03 H 33.64 L 31.11 C 31.28 V 28282300; 2026-10-19 O 32.35 H 32.44 L 30.29 C 30.78 V 25836200.

Context: return_5d_pct ≈ -15.1% (from 2026-10-12 close 36.27); high_20d 47.91 (2026-09-28); low_20d 30.03 (2026-10-15); avg_volume_20d ≈ 25.5M shares (arithmetic mean of completed sessions including latest).

Intraday evidence at answering time: latest_price $31.55, quote_time 2026-10-20T16:30:00Z approx (midday EDT), source https://finance.yahoo.com/quote/IONQ and https://stockanalysis.com/stocks/ionq, live regular-session. PARTIAL SESSION: open 30.28, high_so_far 32.17, low_so_far 30.19, cumulative_volume ~11M (as-of ~12:30 EDT). Relative intraday volume cannot be established versus full-day avg. Pre-event path was post-dilution decline; observed reaction is modest recovery from prior close; remaining window expects range-bound action around the quote with dilution overhang still present.

Catalyst assessment: Verified recent news (equity offering, Elisity deal, DARPA Stage C, Cambridge centre) primarily sentiment/dilution near-term; fundamentals (cash runway, tech milestones) longer-term. No verified catalyst inside the scored window.

Counter-evidence: Oct 15 9.3% rebound on high volume after offering announcement shows buyers can appear quickly; today's partial recovery from $30.78 close is consistent with short-covering or bargain hunting.

Invalidation: A verified close above the Oct 15 high of $34.36 on volume >30M would undermine the neutral short-horizon view by indicating absorption of the share increase.

Other models on the same question

ModelExpected rangeConfidenceResultScore
Muse Spark 1.1$28.50 to $32.8032%Direction called incorrectly11.7
Perplexity$29.50 to $34.5042%Direction called incorrectly21.2
DeepSeek$29.70 to $33.4054%Direction called incorrectly30.3
GPT-6$29.40 to $33.3054%Direction called incorrectly31.5
Claude Sonnet 5.5$29.90 to $33.3030%Direction called correctly77.3
Gemini 3 Pro$30.20 to $33.0060%Direction called correctly80.3

How this forecast is measured

Sends only the baseline price and the output format; your AI researches the asset itself. Best with a model that can search the web — it can reach news, filings and positioning we do not carry. Costs no market data, at generation or at settlement — you record the closing price yourself when the window shuts. The monthly allowance is what a membership buys, not a data bill.

Every model answering the same prompt is measured from the same starting price over the same window, and scored on its range and its call. How scoring works · All shared research.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.